Strengthen your HER2 treatment
PERJETA® (pertuzumab), a targeted therapy, works together with Herceptin® (trastuzumab) and docetaxel to target and block HER2+ breast cancer
A free program that provides PERJETA information and resources to
An easy-to-use app from Genentech for patients with HER2-positive
Financial Assistance Resources
Find out which assistance option might be right for you by using our
Patient Assistance Tool.